ArticleClinical and molecular hepatology2020

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Byoung Kuk JangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.